神经科指南

订阅

MedSci主页 / 所有栏目 / 神经科指南

2021 ICCS共识文件：儿童和青少年神经发育障碍和尿失禁—注意缺陷/多动障碍、自闭症谱系障碍和智力残疾

2021-09-29 国际儿童尿控协会 Neurourol Urodyn

神经发育障碍

本文介绍了三种最重要的NDs，包括注意缺陷／多动障碍、自闭症谱系障碍和智力残疾。

中文标题：

2021 ICCS共识文件：儿童和青少年神经发育障碍和尿失禁—注意缺陷/多动障碍、自闭症谱系障碍和智力残疾

英文标题：

Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability-A consensus document of the International Children's Continence Socie

发布机构：

国际儿童尿控协会

发布日期：

2021-09-29

简要介绍：

2021年9月，国际儿童尿控协会(ICCS)发布了儿童和青少年神经发育障碍和尿失禁共识文件，神经发育障碍（NDs）是一种致残性疾病，在声明早期开始出现，主要由遗传和神经生物学因素引起，并有持续存在的趋势。本文介绍了三种最重要的NDs，包括注意缺陷／多动障碍、自闭症谱系障碍和智力残疾。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ICCS共识文件：儿童和青少年神经发育障碍和尿失禁—注意缺陷／多动障碍、自闭症谱系障碍和智力残疾.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6ccf81c002198eaa, title=2021 ICCS共识文件：儿童和青少年神经发育障碍和尿失禁—注意缺陷/多动障碍、自闭症谱系障碍和智力残疾, enTitle=Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability-A consensus document of the International Children's Continence Socie, guiderFrom=Neurourol Urodyn, authorId=0, author=, summary=本文介绍了三种最重要的NDs，包括注意缺陷／多动障碍、自闭症谱系障碍和智力残疾。, cover=https://img.medsci.cn/2021930/1633005588020_5579292.jpg, journalId=0, articlesId=null, associationId=1098, associationName=国际儿童尿控协会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Sep 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年9月，国际儿童尿控协会(ICCS)发布了儿童和青少年神经发育障碍和尿失禁共识文件，神经发育障碍（NDs）是一种致残性疾病，在声明早期开始出现，主要由遗传和神经生物学因素引起，并有持续存在的趋势。本文介绍了三种最重要的NDs，包括注意缺陷／多动障碍、自闭症谱系障碍和智力残疾。</span></p>, tagList=[TagDto(tagId=79662, tagName=神经发育障碍)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=79662, guiderKeyword=神经发育障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=42700, appHits=169, showAppHits=0, pcHits=1861, showPcHits=42530, likes=0, shares=15, comments=11, approvalStatus=1, publishedTime=Thu Sep 30 20:43:13 CST 2021, publishedTimeString=2021-09-29, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Sep 30 20:41:41 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 13:40:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ICCS共识文件：儿童和青少年神经发育障碍和尿失禁—注意缺陷／多动障碍、自闭症谱系障碍和智力残疾.pdf)])
2021 ICCS共识文件：儿童和青少年神经发育障碍和尿失禁—注意缺陷／多动障碍、自闭症谱系障碍和智力残疾.pdf
下载请点击：
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1182826, encodeId=34a1118282608, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86a6162114, createdName=ms8000001187607950, createdTime=Mon Jan 10 14:22:06 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076259, encodeId=b7f310e62591b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0f4817372, createdName=anyeguzhu, createdTime=Thu Dec 02 16:34:55 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065381, encodeId=4a38106538152, content=太方便了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/5a1c73ff484248b5943b8d70bf706312/8b39f525ce334ef7ab44b83fa5db58ac.jpg, createdBy=3aa05680842, createdName=ms9000001178071774, createdTime=Sat Oct 30 23:03:09 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063454, encodeId=b8c4106345476, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKw3pJ6oNAwtyDJgoTlfpoCxFs2G96icQcgIOZKFGgum0Ct6UOcsJSWUkvdSto7gUdBDZMADN8DTzQ/0, createdBy=0a412237351, createdName=店小九, createdTime=Sun Oct 24 15:12:04 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061169, encodeId=ef0f10611699c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Sun Oct 17 08:22:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2022-01-10 ms8000001187607950

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1182826, encodeId=34a1118282608, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86a6162114, createdName=ms8000001187607950, createdTime=Mon Jan 10 14:22:06 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076259, encodeId=b7f310e62591b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0f4817372, createdName=anyeguzhu, createdTime=Thu Dec 02 16:34:55 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065381, encodeId=4a38106538152, content=太方便了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/5a1c73ff484248b5943b8d70bf706312/8b39f525ce334ef7ab44b83fa5db58ac.jpg, createdBy=3aa05680842, createdName=ms9000001178071774, createdTime=Sat Oct 30 23:03:09 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063454, encodeId=b8c4106345476, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKw3pJ6oNAwtyDJgoTlfpoCxFs2G96icQcgIOZKFGgum0Ct6UOcsJSWUkvdSto7gUdBDZMADN8DTzQ/0, createdBy=0a412237351, createdName=店小九, createdTime=Sun Oct 24 15:12:04 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061169, encodeId=ef0f10611699c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Sun Oct 17 08:22:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-12-02 anyeguzhu

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1182826, encodeId=34a1118282608, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86a6162114, createdName=ms8000001187607950, createdTime=Mon Jan 10 14:22:06 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076259, encodeId=b7f310e62591b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0f4817372, createdName=anyeguzhu, createdTime=Thu Dec 02 16:34:55 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065381, encodeId=4a38106538152, content=太方便了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/5a1c73ff484248b5943b8d70bf706312/8b39f525ce334ef7ab44b83fa5db58ac.jpg, createdBy=3aa05680842, createdName=ms9000001178071774, createdTime=Sat Oct 30 23:03:09 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063454, encodeId=b8c4106345476, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKw3pJ6oNAwtyDJgoTlfpoCxFs2G96icQcgIOZKFGgum0Ct6UOcsJSWUkvdSto7gUdBDZMADN8DTzQ/0, createdBy=0a412237351, createdName=店小九, createdTime=Sun Oct 24 15:12:04 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061169, encodeId=ef0f10611699c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Sun Oct 17 08:22:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-10-30 ms9000001178071774

    太方便了，谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1182826, encodeId=34a1118282608, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86a6162114, createdName=ms8000001187607950, createdTime=Mon Jan 10 14:22:06 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076259, encodeId=b7f310e62591b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0f4817372, createdName=anyeguzhu, createdTime=Thu Dec 02 16:34:55 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065381, encodeId=4a38106538152, content=太方便了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/5a1c73ff484248b5943b8d70bf706312/8b39f525ce334ef7ab44b83fa5db58ac.jpg, createdBy=3aa05680842, createdName=ms9000001178071774, createdTime=Sat Oct 30 23:03:09 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063454, encodeId=b8c4106345476, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKw3pJ6oNAwtyDJgoTlfpoCxFs2G96icQcgIOZKFGgum0Ct6UOcsJSWUkvdSto7gUdBDZMADN8DTzQ/0, createdBy=0a412237351, createdName=店小九, createdTime=Sun Oct 24 15:12:04 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061169, encodeId=ef0f10611699c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Sun Oct 17 08:22:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-10-24 店小九

    谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1182826, encodeId=34a1118282608, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86a6162114, createdName=ms8000001187607950, createdTime=Mon Jan 10 14:22:06 CST 2022, time=2022-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076259, encodeId=b7f310e62591b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0f4817372, createdName=anyeguzhu, createdTime=Thu Dec 02 16:34:55 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065381, encodeId=4a38106538152, content=太方便了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211030/5a1c73ff484248b5943b8d70bf706312/8b39f525ce334ef7ab44b83fa5db58ac.jpg, createdBy=3aa05680842, createdName=ms9000001178071774, createdTime=Sat Oct 30 23:03:09 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063454, encodeId=b8c4106345476, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKw3pJ6oNAwtyDJgoTlfpoCxFs2G96icQcgIOZKFGgum0Ct6UOcsJSWUkvdSto7gUdBDZMADN8DTzQ/0, createdBy=0a412237351, createdName=店小九, createdTime=Sun Oct 24 15:12:04 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061169, encodeId=ef0f10611699c, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=110, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Sun Oct 17 08:22:48 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-10-17 ms3000001999686436

    谢谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

拓展阅读

WHO 康复干预措施包：模块 5：神经发育障碍：网络附件：文献综述和证据表

世界卫生组织(WHO,The World Health Organization) · 2023-07-07

WHO 康复干预措施包：模块 5：神经发育障碍

世界卫生组织(WHO,The World Health Organization) · 2023-07-05

WHO ICD-11 精神、行为和神经发育障碍 (CDDR) 的临床描述和诊断要求

世界卫生组织(WHO,The World Health Organization) · 2024-03-08